The Surface-Level Query We Got:
“Hey, we’re closing our Series A. The foreign VC is asking for a legal DD – just need someone to review our contracts and give us a green flag before next week.”
What We Uncovered:
The founder was building a pharma-tech platform offering supply chain digitisation to government-run procurement systems, with upstream analytics built on hospital tender data. The “quick DD review” request, upon expansion, revealed far deeper legal blind spots not just around contracts, but around:
- Compliance with state-specific pharmacy and lab rules,
- Government procurement codes,
- Data capture and patient privacy implications,
- Unstructured early vendor onboarding,
- And ambiguous ownership of core algorithmic IP.
Risk Zones Table:
| Legal Risk Zone | Urgency | Business Impact | Ideal Lawyer Profile |
| Government procurement regulation | High | Could derail funding or restrict market access | Lawyer with state-level government contracting and public tender compliance experience |
| Health data privacy & analytics use | High | Exposure to regulatory scrutiny and patient rights violations | Tech and health law hybrid with DPDP + HIPAA analog advisory expertise |
| Early vendor & consultant contracts | Medium | Risk of vendor claims over product IP or deliverables | Commercial contracts expert with IP alignment experience |
| Algorithm ownership and licensing | High | Investor concern on asset control and valuation | IP strategist with SaaS product structuring experience |
| Foreign investment structuring | Medium | FDI-compliance and board control clarity | Corporate counsel with cross-border investment structuring background |
Our Lawyer Matching Response:
Instead of routing this to a generalist corporate lawyer with a standard DD checklist, we segmented the mandate into:
- A regulatory diligence and procurement expert for the public health touchpoints,
- An IP-focused commercial contracts lawyer for founder-ownership cleanup,
- A data protection specialist to flag DPDP and analytics risk areas,
- And an experienced VC-facing counsel to re-negotiate terms on data ownership representations and warranties.
All the three lawyers:
- Had past experience working on pharma tender touchpoints and state-level licensing;
- Their communication style was clear and founder-accessible;
- And their diligence strategy could help the client close without triggering renegotiation.
Why This Matters
For Founders:
“DD is just formality” is one of the most expensive illusions. It’s often the first real stress test of your legal hygiene and the easiest time to lose capital or credibility if your regulatory strategy is unclear.
For Lawyers:
Founders won’t always ask the right legal questions – especially in niche sectors where urgency masks complexity. Your job is not just to do what’s asked, but to see what’s missing, expand the scope responsibly, and introduce caution where the client lacks it. In this case, a seemingly simple DD request hid layered regulatory risks, unclear IP chains, and entity-level licensing exposure. A lawyer who simply delivered on the surface ask would’ve left the client vulnerable. The real value lies in going deeper, even when you weren’t explicitly asked to.
For Accelerators and VCs:
When early-stage companies operating in regulated sectors like pharma or health-tech skip proper legal onboarding, it becomes your problem during funding. Structured lawyer matches at early stages reduce friction, speed up closings, and protect investor confidence.
